CRNX - Crinetics Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRNX is currently covered by 11 analysts with an average price target of $71.95. This is a potential upside of $30.85 (75.06%) from yesterday's end of day stock price of $41.1.

Crinetics Pharmaceuticals's activity chart (see below) currently has 125 price targets and 109 ratings on display. The stock rating distribution of CRNX is 95.65% BUY and 4.35% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.94% with an average time for these price targets to be met of 502.4 days.

Highest price target for CRNX is $105, Lowest price target is $52, average price target is $76.5.

Most recent stock forecast was given by RICHARD LAW from GOLDMAN SACHS on 12-Jan-2026. First documented stock forecast 13-Aug-2018.

Currently out of the existing stock ratings of CRNX, 22 are a BUY (95.65%), 1 are a HOLD (4.35%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Jan-2026

$67

$25.9 (63.02%)

$40

1 months 18 days ago
(12-Jan-2026)

1/2 (50%)

$11.65 (21.05%)

42

Buy Since 30-Nov-2021

$105

$63.9 (155.47%)

$108

1 months 22 days ago
(08-Jan-2026)

9/20 (45%)

$51.76 (97.22%)

394

Buy Since 16-Jan-2024

$80

$38.9 (94.65%)

$77

1 months 24 days ago
(06-Jan-2026)

1/4 (25%)

$34.05 (74.10%)

113

Buy Since 30-Aug-2023

$87

$45.9 (111.68%)

$73

5 months ago
(30-Sep-2025)

5/10 (50%)

$45.35 (108.88%)

146

Buy Since 13-Aug-2018

$88

$46.9 (114.11%)

$39

5 months 1 days ago
(29-Sep-2025)

2/3 (66.67%)

$44.49 (102.25%)

1326

Show more analysts

Please expand the browser size to see the chart

What is CRNX (Crinetics Pharmaceuticals) average time for price targets to be met?

On average it took 502.4 days on average for the stock forecasts to be realized with a an average price target met ratio 54.94

Which analyst has the current highest performing score on CRNX (Crinetics Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on CRNX (Crinetics Pharmaceuticals)?

Charles Duncan has 14 price targets and 8 ratings on CRNX

Which analyst is the currently most bullish on CRNX (Crinetics Pharmaceuticals)?

Jonathan Wolleben with highest potential upside - $63.9

Which analyst is the currently most reserved on CRNX (Crinetics Pharmaceuticals)?

Tyler Van Buren with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?